Venom Bumble Bee (Bombus terrestrus) IgG
The clinical correlates for bumble bee venom IgG responses have not been established and there is no published protective threshold. However, by analogy to other venoms that have been studied, it is expected that increasing concentrations of bumble bee specific IgG will correlate with protection.
ProcedureEnzyme immunoassay (FEIA). A standard curve is used to calculate the specific IgG concentrations. The calibrators are referenced to the International Reference Preparation for serum immunoglobulins. This test has not been cleared or approved for diagnostic use by the U.S. Food and Drug Administration.
3 business days from receipt of specimen
| Specimen Type | Test Code | CPT Code | NY Approved | Volume | Assay Range | Special Instructions |
|---|---|---|---|---|---|---|
| Serum (1) | 91820 | 86001 | Yes | 0.5 mL (min. 150 uL) | See Limit of Quantitation Guide |
|
The units are micrograms/mL of specific IgG. The reference varies by allergen.
| mcg/mL of IgG | |
| Lower Limit of Quantitation | 2.0 |
| Upper Limit of Quantitation | 200 |
Reference ranges vary by allergen.
Causes for RejectionLipemic samples may lead to rejection.
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.